VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,174 | -3.6% | 10,228 | +47.0% | 0.00% | – |
| Q2 2023 | $45,833 | +6.0% | 6,957 | +9.3% | 0.00% | – |
| Q1 2023 | $43,221 | +35.1% | 6,367 | +43.6% | 0.00% | – |
| Q4 2022 | $32,000 | -31.9% | 4,435 | -7.7% | 0.00% | – |
| Q3 2022 | $47,000 | -21.7% | 4,805 | -13.2% | 0.00% | – |
| Q2 2022 | $60,000 | -3.2% | 5,535 | +3.0% | 0.00% | – |
| Q1 2022 | $62,000 | -20.5% | 5,373 | +8.7% | 0.00% | – |
| Q4 2021 | $78,000 | +5.4% | 4,944 | +13.1% | 0.00% | – |
| Q3 2021 | $74,000 | -20.4% | 4,372 | +0.7% | 0.00% | – |
| Q2 2021 | $93,000 | +60.3% | 4,342 | +13.7% | 0.00% | – |
| Q1 2021 | $58,000 | +31.8% | 3,819 | +13.9% | 0.00% | – |
| Q4 2020 | $44,000 | +51.7% | 3,352 | +23.0% | 0.00% | – |
| Q3 2020 | $29,000 | -32.6% | 2,726 | -27.0% | 0.00% | – |
| Q2 2020 | $43,000 | +53.6% | 3,732 | +43.0% | 0.00% | – |
| Q1 2020 | $28,000 | – | 2,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |